Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

1-1-2005

Abstract

Distal balloon occlusion was approved as a means of embolic protection during saphenous vein graft intervention based on its ability to decrease major adverse clinical events (MACEs) by 42% in the 801-patient Saphenous Vein Graft Angioplasty Free of Embol

Publication ISSN

0195-9131

Share

COinS